Skip to main content

MoneyWorks4Me

BSE Healthcare Companies

BSE Sensex 82724.79 620 (0.76%)

The BSE Healthcare Index is designed to reflect the behaviour and performance of mid market capitalization companies. S&P BSE Mid Cap includes all companies forming part of mid cap universe on BSE. Look for Green and Orange companies for investing. Bookmark this page for your easy reference in future.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

BSE Healthcare companies as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Company Name
DeciZen
CMP
Price
Change (%)
Market
Cap (Cr)
52Week
High
52Week
Low
ROE(%)
P/E
P/BV
EV/
EBITDA
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
1
Q V+ PT
190 12.69% 186
08 Oct, 26
70.51
28 Jan, 26
0.00 0.00 0.00 - 0.00 0.00
2
Q V+ PT
1,583 6.41% 1,666
08 Oct, 26
454
12 Jan, 26
14.55 48.54 7.42 21.24 0.00 0.00
3
Q V+ PT
348 6.28% 378
25 Sep, 26
203
13 Apr, 26
11.84 44.33 5.52 21.43 21.50 83.35
4
Q V+ PT
2,336 5.38% 2,482
11 Nov, 26
913
02 Feb, 26
17.86 97.59 21.57 55.03 7.19 -2.25
5
Q V PT
669 5.37% 774
15 Sep, 26
423
30 Mar, 26
-0.44 90.22 2.32 15.86 -3.27 -145.29
6
Q V+ PT
1,114 4.10% 1,183
18 Sep, 26
538
27 Jan, 26
10.40 53.67 5.45 27.90 39.48 45.83
7
Q V+ PT
666 3.87% 781
11 Sep, 26
445
19 Dec, 25
8.72 51.14 5.51 23.14 0.00 0.00
8
Q V+ PT
6,575 3.21% 6,750
12 Nov, 26
5,010
30 Mar, 26
20.45 26.20 4.95 13.83 18.09 25.97
9
Q V PT
353 2.77% 381
11 Nov, 26
224
30 Mar, 26
14.20 42.55 6.44 15.15 17.26 -44.22
10
Q V+ PT
528 2.71% 839
18 Nov, 25
462
02 Nov, 26
10.89 17.48 1.69 7.46 0.00 0.00
11
Q V+ PT
18.83 2.56% 56.99
25 May, 26
17.72
08 Nov, 26
0.00 0.00 0.00 - 0.00 0.00
12
Q V PT
1,001 2.45% 1,181
07 Sep, 26
699
16 Mar, 26
12.02 31.18 3.69 17.14 16.15 12.78
13
Q V PT
2,714 2.43% 3,121
28 Aug, 26
2,088
12 Jun, 26
45.95 39.44 24.04 27.75 5.49 17.52
14
Q V PT
1,359 2.38% 1,737
09 Dec, 25
1,069
26 Oct, 26
18.68 25.68 4.38 17.37 20.89 11.86
15
Q V PT
6,176 2.37% 9,449
18 Nov, 25
5,660
09 Oct, 26
0.00 0.00 0.00 - 0.00 0.00
16
Q V+ PT
1,009 2.29% 1,025
16 Nov, 26
584
30 Mar, 26
10.53 37.30 4.31 19.52 0.00 0.00
17
Q V+ PT
243 2.28% 268
07 Oct, 26
121
30 Mar, 26
9.73 31.26 2.61 18.73 28.00 58.07
18
Q V PT
162 1.89% 210
01 Oct, 26
98.25
23 Jan, 26
11.14 64.77 4.67 35.94 0.00 0.00
19
Q V+ PT
814 1.81% 922
15 Sep, 26
520
02 Mar, 26
10.58 56.82 3.91 28.91 2.07 -5.88
20
Q V+ PT
703 1.70% 814
28 Aug, 26
598
23 Oct, 26
13.23 100.24 5.39 33.12 41.64 0.00
21
Q V+ PT
271 1.52% 296
30 Sep, 26
107
30 Mar, 26
7.04 35.54 2.65 18.85 6.74 -8.11
22
Q V PT
1,205 1.38% 1,266
04 Nov, 26
836
02 Apr, 26
17.64 28.42 4.27 15.04 13.52 14.72
23
Q V PT
1,022 1.22% 1,187
24 Nov, 25
797
22 Oct, 26
14.68 66.62 8.12 35.99 27.27 155.29
24
Q V+ PT
1,692 1.17% 1,896
28 Aug, 26
610
09 Dec, 25
26.97 85.58 19.63 54.27 41.00 54.29
25
Q V PT
1,350 1.11% 1,750
19 Jan, 26
1,084
02 Jun, 26
20.04 19.64 3.45 12.13 -8.95 -14.52
26
Q V+ PT
28.52 1.10% 40.75
01 Dec, 25
16.74
30 Mar, 26
-0.23 43.78 2.02 20.00 19.91 -146.99
27
Q V PT
39.00 1.06% 49.98
20 Aug, 26
23.12
28 Jan, 26
12.31 19.99 1.81 12.93 4.33 3.30
28
Q V PT
323 1.05% 468
02 Dec, 25
272
18 May, 26
0.00 0.00 0.00 - 0.00 0.00
29
Q V+ PT
573 0.98% 771
31 Aug, 26
513
30 Mar, 26
3.80 2194.63 5.30 32.39 17.43 0.00
30
Q V PT
201 0.88% 315
17 Nov, 25
156
30 Mar, 26
14.04 34.60 4.23 18.85 0.00 0.00
31
Q V PT
5,185 0.88% 5,933
13 Jan, 26
4,880
22 Oct, 26
18.04 29.55 4.11 16.55 10.66 8.92
32
Q V PT
2,329 0.80% 2,669
30 Jul, 26
1,251
01 Apr, 26
14.93 14.03 4.26 19.09 9.19 6.34
33
Q V PT
444 0.76% 493
11 Nov, 26
268
30 Mar, 26
10.10 64.38 6.88 30.20 0.00 0.00
34
Q V PT
138 0.66% 257
17 Nov, 25
115
23 Oct, 26
9.70 17.46 1.42 8.80 0.00 0.00
35
Q V PT
1,441 0.61% 1,542
27 Aug, 26
955
30 Mar, 26
15.21 63.20 9.04 31.40 24.97 76.92
36
Q V PT
1,031 0.56% 1,350
23 Sep, 26
608
02 Mar, 26
12.92 39.65 5.91 24.69 31.75 26.73
37
Q V PT
238 0.55% 298
06 Jul, 26
178
23 Mar, 26
7.36 48.48 4.01 15.00 20.23 2.33
38
Q V+ PT
510 0.51% 721
17 Nov, 25
477
16 Sep, 26
18.41 25.69 3.83 15.05 8.59 1.17
39
Q V PT
1,387 0.50% 1,414
29 Jun, 26
1,080
23 Jul, 26
10.90 41.08 2.96 19.17 12.09 15.75
40
Q V+ PT
218 0.44% 261
04 Dec, 25
146
30 Mar, 26
0.24 0.00 2.32 11.87 -0.09 -53.23
41
Q V+ PT
1,875 0.43% 2,048
31 Jul, 26
1,584
29 Jan, 26
14.80 41.15 5.05 21.32 11.78 14.41
42
Q V PT
1,902 0.42% 2,094
17 Nov, 25
1,564
30 Mar, 26
20.68 44.32 7.61 20.14 25.04 0.00
43
Q V+ PT
1,795 0.37% 1,857
11 Nov, 26
1,106
10 Feb, 26
10.64 38.48 4.50 26.41 -6.73 -4.90
44
Q V PT
95.38 0.37% 141
07 Sep, 26
65.00
30 Mar, 26
0.03 23.39 2.22 -31.31 8.21 -69.58
45
Q V+ PT
3,958 0.36% 4,133
13 Nov, 26
1,571
21 Jan, 26
22.51 75.37 17.82 50.78 31.50 70.35
46
Q V+ PT
2,347 0.34% 2,395
13 Nov, 26
1,325
18 Nov, 25
18.35 40.92 8.37 21.90 8.73 13.15
47
Q V+ PT
11,146 0.32% 11,818
09 Nov, 26
5,648
02 Apr, 26
15.58 90.70 16.95 60.00 8.67 4.44
48
Q V+ PT
2,010 0.29% 2,420
01 Jun, 26
1,087
23 Mar, 26
4.70 80.48 6.40 39.34 4.49 0.00
49
Q V+ PT
8,782 0.29% 9,327
03 Aug, 26
6,680
28 Jan, 26
16.08 75.26 11.43 42.26 14.92 0.00
50
Q V+ PT
964 0.27% 1,175
18 Nov, 25
784
10 Mar, 26
6.36 58.45 2.16 15.09 6.31 -7.74

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
189.65 12.69%
1,582.65 6.41%
347.70 6.28%
2,336.40 5.38%
668.55 5.37%

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
130.85 -6.37%
335.05 -4.18%
555.95 -4.06%
91.30 -3.69%
348.75 -3.04%

News about BSE Healthcare

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sun Pharma Advanced Research Company Ltd. (S) Not Good 193 6,679 4.08 4.63 3.33 280
Wanbury Ltd. (S) Very Good 177 677 15.75 4.31 9.61 69.35
Glaxosmithkline Pharmaceuticals Ltd. (M) Very Good 2,714 45,224 39.44 24.04 27.75 45.95
Sanofi India Ltd. (S) Somewhat Good 3,245 7,606 18.40 0.00 14.41 36.06
Abbott India Ltd. (M) Very Good 25,999 56,127 33.96 13.14 23.49 34.24

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Acutaas Chemicals Ltd. (S) Somewhat Good 3,958 33,100 130
Laurus Labs Ltd. (M) Very Good 2,336 1,30,756 122
Sai Life Sciences Ltd. (S) Somewhat Good 1,747 41,007 107
Gland Pharma Ltd. (M) Very Good 3,287 55,026 84.56
Divis Laboratories Ltd. (L) Very Good 11,146 3,05,014 70.64
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
RPG Life Sciences Ltd. (S) Somewhat Good 2,553 4,220 38.58 6.14 22.71 42.67
Manipal Health Enterprises Ltd. (M) Very Good 703 89,446 100 5.39 33.12 41.64
Rubicon Research Ltd. (S) Somewhat Good 1,692 27,799 85.58 19.63 54.27 41.00
Yatharth Hospital & Trauma Care Services Ltd. (S) Somewhat Good 1,114 10,225 53.67 5.45 27.90 39.48
Dr. Agarwals Health Care Ltd. (S) Very Good 544 17,482 101 7.81 25.44 34.58

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Max Healthcare Institute Ltd. (M) N/A 1,022 91,979 66.62 8.12 35.99 155
Artemis Medicare Services Ltd. (S) Somewhat Good 348 5,086 44.33 5.52 21.43 83.35
Global Health Ltd. (S) Somewhat Good 1,441 39,083 63.20 9.04 31.40 76.92
Acutaas Chemicals Ltd. (S) Somewhat Good 3,958 33,100 75.37 17.82 50.78 70.35
Kilitch Drugs (India) Ltd. (S) Not Good 243 753 31.26 2.61 18.73 58.07
You’ve reached your free data limit. Unlock unlimited data views for free. Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me has been helping investors make better investment decisions since 2008.

MoneyWorks4Me Investment Advisers is the trade/brand name of The Alchemists Ark Pvt. Ltd., a SEBI-registered non-individual Investment Adviser (Registration No. INA000013323).

We began in 2008 as an equity research company, helping investors identify high-quality Indian businesses and understand what they were worth through deep fundamental research and intrinsic-value-based investing.

Over time, we learnt that successful investing requires much more than identifying good stocks.

Investors also need to know how much to invest, how to allocate money across different assets, how to construct a strong portfolio, when to act and, equally importantly, when not to.

That understanding shaped our evolution from an equity research company into a broader investment company built around research, portfolio strategy, technology and human judgement.

One Investing Philosophy. Different Ways to Benefit From It.

Today, our capabilities extend across Indian direct equities, mutual funds, global equities, fixed income, gold and REITs and other suitable investment opportunities.

We do not see these as separate investment products. They are different building blocks of one portfolio.

The starting point is the investor: their goals, required returns, time horizon, ability to take risk and the role each asset needs to play.

Asset allocation determines where the money should go.Research and valuation guide what we own. Portfolio construction determines how much we own.Periodic review and rebalancing help keep the portfolio aligned with its purpose.

This investment philosophy is applied in different ways across MoneyWorks4Me.

Through Omega Freedom and Omega Legacy, we work closely with investors who want comprehensive investment advice and guidance in managing their portfolios.

Through Third Rock Wealth, we bring the same investment thinking and research depth to investors who prefer mutual funds as their route to wealth creation.

Research at the Core

We look at business quality, financial strength, competitive advantage, management, growth prospects and risks. But we always consider these alongside valuation.

A good company does not automatically make a good investment at every price.

Our Quality-at-a-Reasonable-Price approach seeks to bring quality and valuation together.

Start With the Portfolio

We do not begin by asking which stock, fund or asset looks attractive.

We begin by asking what the portfolio needs.

Indian equities may provide long-term growth. Global equities can broaden diversification. Fixed income can provide stability and liquidity. Gold has a different role to play.

Every investment should earn its place in the portfolio.

Focus on Process, Not Prediction

Markets cannot be predicted consistently. A sound investment process can be followed consistently.

We therefore focus on what can be controlled: asset allocation, quality, valuation, diversification, position sizing, risk management, review and taking action when required.

Let Compounding Do the Heavy Lifting

Long-term wealth is not created only by finding investments with spectacular returns.

It comes from putting money to work intelligently, earning satisfactory inflation-beating returns across the portfolio and staying invested long enough for compounding to make a meaningful difference.

Technology Has Always Been Part of MoneyWorks4Me

Technology has been integral to MoneyWorks4Me from the beginning, from our financial X-Rays and valuation tools to portfolio analytics and research systems.

Over the years, we have accumulated company research, financial data, valuation work, investment frameworks and insights.

The aim is to make it easier for investors and our teams to work with years of MoneyWorks4Me research, data and investment thinking.

It is not intended to replace human judgement.

Investing still involves context, uncertainty and decisions for which there is not always an obvious answer.

Investors Should Understand Why

Our advisory business operates in a fiduciary capacity, and the investor's interests come first.

We believe investors should understand the reasoning behind important investment decisions rather than simply follow recommendations.

That is the thinking behind our Do-It-With-Me approach.

It is designed to help investors remain in control of their money while benefiting from professional research, process and perspective.

Our Vision

Our vision is to build a trusted, research-powered investment company that helps investors make calm, informed and well-reasoned decisions throughout their investing journey.

Markets will change. Investment opportunities will change. Technology will change how investors access information and advice.

But the principles of successful investing are far more enduring:own quality assets at sensible prices, build portfolios intelligently, manage risk and give compounding enough time to work.

That is the investment discipline MoneyWorks4Me has been building since 2008 and continues to strengthen for the future.